Life360's Board of Directors has approved a multi-year share repurchase program worth up to $225 million to reduce dilution from stock-based compensation. The program aims to return value to shareholders and is supported by the company's strong balance sheet and consistent positive cash flow over twelve quarters. Life360 will repurchase shares through various market methods at management's discretion, with no fixed commitment on timing or amount. This move reflects confidence in the company's business model and long-term cash flow generation as it continues to grow its global user base.
President Donald Trump secured a major deal with China, where China agreed to purchase at least $17 billion worth of US agricultural products annually until 2028. This agreement was announced after a two-day summit in China, the first by a US preside...
Former President Donald Trump issued a stern warning to Iran, urging swift action in stalled peace negotiations or face severe consequences. He rejected Iran's demand to separate nuclear talks from peace discussions, emphasizing that time is critical...
Design Therapeutics, a clinical-stage biotech company, will announce data from its ongoing Phase 1/2 RESTORE-FA trial of DT-216P2, a treatment for Friedreich’s ataxia, on May 18, 2026. The company will host a live webcast and conference call to discu...
Novartis announced that combining Pluvicto (lutetium-177 vipivotide tetraxetan) with standard care (ARPI + ADT) significantly improves PSA response in metastatic hormone-sensitive prostate cancer (mHSPC), reducing PSA progression risk by 58% compared...
The iShares 20+ Year Treasury Bond ETF (TLT) saw $122 million in outflows last week amid rising US bond yields driven by higher inflation and hawkish Federal Reserve signals. April's inflation data showed consumer prices jumping to 3.8% and producer ...
